Page last updated: 2024-10-19

orotic acid and Depressive Disorder, Treatment-Resistant

orotic acid has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bambling, M1
Edwards, SC1
Hall, S1
Vitetta, L1

Trials

1 trial available for orotic acid and Depressive Disorder, Treatment-Resistant

ArticleYear
A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested.
    Inflammopharmacology, 2017, Volume: 25, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents; Cohort Studies; Depressive Disorder, Treatme

2017